Resultados financieros en millones de dólares estadounidenses. El ejercicio fiscal es febrero - enero.
Breakdown
TTM
09/30/2025
09/30/2024
09/30/2023
09/30/2022
09/30/2021
Ingresos
6,037
6,037
5,391
4,775
4,444
4,013
Crecimiento de los Ingresos (YoY)
12%
12%
13%
7%
11%
13%
Costo de los ingresos
2,404
2,404
2,190
2,062
1,862
1,510
Utilidad bruta
3,633
3,633
3,201
2,713
2,582
2,503
Venta, General y Administración
2,502
2,425
2,161
2,051
2,078
1,874
Investigación y Desarrollo
137
137
115
107
131
116
Gastos de Operación
2,849
2,849
2,556
2,411
2,432
2,163
Otras Ingresos (Gastos) No Operativos
--
--
0
-1
-2
-4
Ingreso antes de impuestos
755
755
300
210
109
308
Gasto por Impuesto a la Renta
146
146
65
42
16
61
Ingreso Neto
609
609
235
168
93
247
Crecimiento de la Utilidad Neta
159%
159%
40%
81%
-62%
2%
Acciones en Circulación (Diluidas)
264.82
266.47
266.33
260.48
253.98
251.77
Cambio de Acciones (YoY)
-1%
0%
2%
3%
1%
2%
EPS (Diluido)
2.28
2.28
0.88
0.64
0.36
0.98
Crecimiento de EPS
158%
159%
37%
76%
-63%
0%
Flujo de efectivo libre
407
407
524
192
-463
-256
Flujo de efectivo libre por acción
--
--
--
--
--
--
Margen bruto
60.17%
60.17%
59.37%
56.81%
58.1%
62.37%
Margen de operación
12.98%
12.98%
11.96%
6.32%
3.37%
8.47%
Margen de beneficio
10.08%
10.08%
4.35%
3.51%
2.09%
6.15%
Margen de flujo de caja libre
6.74%
6.74%
9.71%
4.02%
-10.41%
-6.37%
EBITDA
1,156
1,154
1,000
650
501
556
Margen de EBITDA
19.14%
19.11%
18.54%
13.61%
11.27%
13.85%
D&A para EBITDA
372
370
355
348
351
216
EBIT
784
784
645
302
150
340
Margen de EBIT
12.98%
12.98%
11.96%
6.32%
3.37%
8.47%
Tasa de Impuesto Efectiva
19.33%
19.33%
21.66%
20%
14.67%
19.8%
Estadísticas clave
Cierre Anterior
$12.94
Precio de apertura
$12.94
Rango del día
$12.94 - $12.94
Rango de 52 semanas
$12.56 - $20.24
Volumen
1.0K
Volumen promedio
204
EPS (TTM)
0.37
Rendimiento de dividendos
--
Cap. de mercado
$2.9B
¿Qué es Ambu A/S?
Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. The Company’s operations are structured into three business areas: Anaesthesia, Patient Monitoring & Diagnostics and Emergency Care. The Anaesthesia business area offers a range of products such as resuscitators, face masks and laryngeal masks. The Patient Monitoring & Diagnostics business area comprises single use electrodes for cardiological and neurological examinations. The target groups for these products are hospitals, clinics, ambulance services and sleep labs. The Emergency Care business area offers ventilation bags, neck collars and manikins for first-aid training. The firm markets its products worldwide. The firm operates King Systems Inc, First Water Heathcote Ltd and Invendo Medical GmbH as subsidiaries.